Connect your AI

Current Assets

Medtronic·Balance Sheet Statement·27 metrics

Breakdown

Metric	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26	Q2 '26	Q3 '26
Finished goods	$3.7B	$3.7B	$3.7B	$3.7B	$3.8B	$4B	$4.2B	$4.2B
Raw materials	$907M	$986M	$1B	$1.1B	$953M	$1.1B	$1.1B	$1.2B
Work in process	$642M	$696M	$728M	$782M	$744M	$792M	$853M	$883M
Inventories	$5.2B	$5.4B	$5.5B	$5.6B	$5.5B	$5.9B	$6.2B	$6.3B

Metrics

Accounts receivable, net

Available-for-Sale Debt Securities - Amortized Cost

Available-for-Sale Debt Securities - Amortized Cost (Due Within One Year)

Available-for-Sale Debt Securities - Unrealized Loss Position (>=12 Months)

AFS and Trading Securities - Unrealized Loss Position (>=12 Months)

AFS and Trading Securities - Unrealized Loss Position (<12 Months) Fair Value

Available-for-Sale Debt Securities - Unrealized Loss Position (<12 Months)

AFS and Trading Securities - Unrealized Loss Position (>=12 Months) Fair Value

AFS and Trading Securities - Unrealized Loss Position (<12 Months) Fair Value

Allowance for Doubtful Accounts

Allowance for Doubtful Accounts Receivable (Current)

Cash and cash equivalents

Finished goods

Other current assets

Derivative Assets - Fair Value

Derivative Assets - Net Reduction from Master Netting Arrangements

Derivative assets

Trading assets

Finished goods

Raw materials

Work in process

Inventories

Net Cash Collateral Received - Derivative Instruments

Prepaid expenses and other current assets

Short-term investments

Total current assets

Trading Securities in Marketable Securities